Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1967 Nov;20(6):896–904. doi: 10.1136/jcp.20.6.896

Use of diethylenetriamine penta-acetic acid (D.T.P.A.) in the clinical assessment of total body iron stores

L W Powell 1, M J Thomas 1
PMCID: PMC473636  PMID: 5614075

Abstract

As a quantitative test of iron storage the six-hour urinary excretion of iron was measured after the intravenous infusion of the iron-chelating agent diethylenetriamine penta-acetic acid (D.T.P.A.). The value of this test in determining the presence and magnitude of the total body iron stores was assessed in patients with diseases of iron storage. In patients with idiopathic haemochromatosis and in their first-degree relatives with increased iron stores as measured by hepatic biopsy, the result of the D.T.P.A. test fell progressively as iron stores were reduced by venesection therapy. There was a significant correlation between the result of the D.T.P.A. test and the excess iron storage as measured retrospectively by the effects of venesection therapy, and also between the D.T.P.A. test and the unsaturated iron-binding capacity (U.I.B.C.) in these patients.

In patients with excess iron stores due to diseases other than idiopathic haemochromatosis (e.g., alcoholic cirrhosis, haemochromatosis associated with refractory anaemia) the D.T.P.A. test demonstrated the presence of excess iron stores, but the results were very variable and did not correlate closely with the U.I.B.C. or the degree of hepatic haemosiderin deposits. Unexpectedly high results for the D.T.P.A. test were found in some patients with iron-deficiency anaemia.

Full text

PDF
896

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Balcerzak S. P., Westerman M. P., Lee R. E., Doyle A. P. Idiopathic hemochromatosis. A study of three families. Am J Med. 1966 Jun;40(6):857–873. doi: 10.1016/0002-9343(66)90201-4. [DOI] [PubMed] [Google Scholar]
  2. Bannerman R. M., Callender S. T., Williams D. L. Effect of Desferrioxamine and D.T.P.A. in Iron Overload. Br Med J. 1962 Dec 15;2(5319):1573–1577. doi: 10.1136/bmj.2.5319.1573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CLETON F., TURNBULL A., FINCH C. A. Synthetic chelating agents in iron metabolism. J Clin Invest. 1963 Mar;42:327–337. doi: 10.1172/JCI104719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CONRAD M. E., Jr, BERMAN A., CROSBY W. H. Iron kinetics in laennec's cirrhosis. Gastroenterology. 1962 Oct;43:385–390. [PubMed] [Google Scholar]
  5. FIELDING J. DIFFERENTIAL FERRIOXAMINE TEST FOR MEASURING CHELATABLE BODY IRON. J Clin Pathol. 1965 Jan;18:88–97. doi: 10.1136/jcp.18.1.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FINCH S. C., BARNETT R. N. Diagnostic and therapeutic phlebotomy in hemochromatosis with anemia; report of a case. N Engl J Med. 1957 May 9;256(19):884–887. doi: 10.1056/NEJM195705092561904. [DOI] [PubMed] [Google Scholar]
  7. Fielding J., O'Shaughnessy M. C., Brunström G. M. Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis. J Clin Pathol. 1966 Mar;19(2):159–164. doi: 10.1136/jcp.19.2.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HASKINS D., STEVENS A. R., Jr, FINCH S., FINCH C. A. Iron metabolism; iron stores in man as measured by phlebotomy. J Clin Invest. 1952 Jun;31(6):543–547. doi: 10.1172/JCI102639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HWANG Y. F., BROWN E. B. EVALUATION OF DEFEROXAMINE IN IRON OVERLOAD. Arch Intern Med. 1964 Dec;114:741–753. doi: 10.1001/archinte.1964.03860120053003. [DOI] [PubMed] [Google Scholar]
  10. LLOYD H. M., POWELL L. W., THOMAS M. J. IDIOPATHIC HAEMOCHROMATOSIS IN MENSTRUATING WOMEN. A FAMILY STUDY, INCLUDING THE USE OF DIETHYLENE TRIAMINE PENTA-ACETIC ACID. Lancet. 1964 Sep 12;2(7359):555–557. doi: 10.1016/s0140-6736(64)90619-1. [DOI] [PubMed] [Google Scholar]
  11. O'Shaughnessy M. C., Brunström G. M., Fielding J. Iron chelation in haematomas at fracture sites. J Clin Pathol. 1966 Jul;19(4):364–367. doi: 10.1136/jcp.19.4.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ploem J. E., de Wael J., Verloop M. C., Punt K. Sideruria following a single dose of desferrioxamine-B as a diagnostic test in iron overload. Br J Haematol. 1966 Jul;12(4):396–408. doi: 10.1111/j.1365-2141.1966.tb05649.x. [DOI] [PubMed] [Google Scholar]
  13. Powell L. W. Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemosiderosis. A comparative study of 27 families. Q J Med. 1965 Oct;34(136):427–442. [PubMed] [Google Scholar]
  14. RAMSAY W. N. The determination of the total iron-binding capacity of serum. Clin Chim Acta. 1957 Jun;2(3):221–226. doi: 10.1016/0009-8981(57)90106-7. [DOI] [PubMed] [Google Scholar]
  15. SCHEUER P. J., WILLIAMS R., MUIR A. R. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacteriol. 1962 Jul;84:53–64. [PubMed] [Google Scholar]
  16. STEVENS E., ROSOFF B., WEINER M., SPENCER H. Metabolism of the chelating agent diethylenetriamine pentaacetic acid (C14DTPA) in man. Proc Soc Exp Biol Med. 1962 Nov;111:235–238. doi: 10.3181/00379727-111-27752. [DOI] [PubMed] [Google Scholar]
  17. Smith P. M., Studley F., Williams R. Assessment of body-iron stores in cirrhosis and haemochromatosis with the differential ferrioxamine test. Lancet. 1967 Jan 21;1(7482):133–136. doi: 10.1016/s0140-6736(67)91035-5. [DOI] [PubMed] [Google Scholar]
  18. TRINDER P. The improved determination of iron in serum. J Clin Pathol. 1956 May;9(2):170–172. doi: 10.1136/jcp.9.2.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Tyrer J. H., Powell L. W., Burnett W. Hémochromatose primitive constitutionnelle ou hémochromatose secondaire à une cirrhose alcoolique? Observation d'un cas compliqué d'hépatome malin et de thrombose de la veine porte. Presse Med. 1966 Apr 30;74(22):1135–1136. [PubMed] [Google Scholar]
  20. WALSH J. R., MASS R. E., SMITH F. W., LANGE V. IRON CHELATION WITH DEFEROXAMINE IN HEPATIC DISEASE. Gastroenterology. 1965 Aug;49:134–140. [PubMed] [Google Scholar]
  21. WALSH R. J., PERKINS K. W., BLACKBURN C. R., SANFORD R., CANTRILL S. THE USE OF DTPA IN THE DIAGNOSIS AND MANAGEMENT OF IDIOPATHIC HAEMOCHROMATOSIS. Australas Ann Med. 1963 Aug;12:192–196. doi: 10.1111/imj.1963.12.3.192. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES